BlackRock Health Sciences Trust II (NYSE:BMEZ) announces a share repurchase program. Under the program, the company will repurchase up to 5% of its outstanding common shares (based on common shares outstanding on November 30, 2022). The purpose of the program is to enhance shareholder value by purchasing fund shares trading at a discount from their net asset value per share, which could result in incremental accretion to a fund's NAV.

The repurchases will commence from December 1, 2022, and the program will be valid till November 30, 2023.